Literature DB >> 11498907

Present situation in preventing and treating liver fibrosis with TCM drugs.

B Du1, S You.   

Abstract

Considerable evidences have shown that the mechanism of TCM drugs for preventing and treating liver fibrosis is very complicated. TCM treatment can not only inhibit viral replication, ameliorate inflammation and promote blood circulation in the liver, and enhance regeneration of the hepatic cells, but also inhibit HSC proliferation, intra- and extracellular secretion, decrease the secretion of collagen and promote its degradation and re-absorption. However, most of the animal models are only suitable for studies of acute hepatitis. Establishment of cell lines suitable for studies of fibrosis is still at its initial stage. What we expect is that comprehensive clinical studies in TCM treatment of liver fibrosis will be carried out and evaluation of each datum given, both of which are of importance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498907

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  5 in total

1.  Effect of Astragalus complanatus flavonoid on anti-liver fibrosis in rats.

Authors:  Chun-Yu Liu; Zhen-Lun Gu; Wen-Xuan Zhou; Ci-Yi Guo
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

2.  Blockage of transforming growth factor beta receptors prevents progression of pig serum-induced rat liver fibrosis.

Authors:  Wei Jiang; Chang-Qing Yang; Wen-Bin Liu; Yi-Qing Wang; Bo-Ming He; Ji-Yao Wang
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

3.  Evaluation of the Chinese Medicinal Herb, Graptopetalum paraguayense, as a Therapeutic Treatment for Liver Damage in Rat Models.

Authors:  Li-Jen Su; Chih-Hsueh Yang; Shiu-Feng Huang; Ya-Ling Yuo; Hui-Chu Hsieh; Tzu-Ling Tseng; Chang-Han Chen; Shih-Lan Hsu; Chi-Ying F Huang
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-02       Impact factor: 2.629

4.  Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis.

Authors:  Yan-yan Tao; Xiu-chuan Yan; Tao Zhou; Li Shen; Zu-long Liu; Cheng-hai Liu
Journal:  BMC Complement Altern Med       Date:  2014-11-18       Impact factor: 3.659

5.  Bupleurum marginatum Wall.ex DC in Liver Fibrosis: Pharmacological Evaluation, Differential Proteomics, and Network Pharmacology.

Authors:  Xiujie Liu; Yu Shi; Yinghui Hu; Ke Luo; Ying Guo; Weiwei Meng; Yulin Deng; Rongji Dai
Journal:  Front Pharmacol       Date:  2018-05-17       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.